Funding source and the quality of reports of chronic wounds trials: 2004 to 2011

Trials

Volumn 15, Issue 1, 2014, Pages

  Hodgson, Robert ^a   Allen, Richard ^a   Broderick, Ellen ^a   Bland, J M ^a   Dumville, Jo C ^b   Ashby, Rebecca ^a   Bell Syer, Sally ^a   Foxlee, Ruth ^a   Hall, Jill ^a   Lamb, Karen ^c   Madden, Mary ^a   O'Meara, Susan ^d   Stubbs, Nikki ^c   Cullum, Nicky ^b  

^a UNIVERSITY OF YORK   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c ST MARY S HOSPITAL   (United Kingdom)

^d UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

Bias; Industry funding; Randomised controlled trials; Wound care

Indexed keywords

GROWTH FACTOR; TOPICAL AGENT;

ARTICLE; BANDAGES AND DRESSINGS; CHRONIC WOUND; COCHRANE LIBRARY; DECUBITUS; FOLLOW UP; FOOT ULCER; FUNDING; HUMAN; INDUSTRY FUNDING; LEG ULCER; OUTCOME ASSESSMENT; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); REGISTER; SAMPLE SIZE; STUDY DESIGN; SYSTEMATIC REVIEW; TISSUE GRAFT; WOUND CARE;

BIAS (EPIDEMIOLOGY); CHRONIC DISEASE; CONFLICT OF INTEREST; HEALTH CARE SECTOR; HUMANS; QUALITY OF HEALTH CARE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN; RESEARCH SUPPORT AS TOPIC; TREATMENT OUTCOME; WOUND HEALING; WOUNDS AND INJURIES;

EID: 84892407699     PISSN: None     EISSN: 17456215     Source Type: Journal    
DOI: 10.1186/1745-6215-15-19     Document Type: Article

References (52)

1. Mustoe T. Understanding chronic wounds: a unifying hypothesis on their pathogenesis and implications for therapy. Am J Surg 2004, 187:65S-70S. 10.1016/S0002-9610(03)00306-4, 15147994.
2. Watson J, Kang'ombe A, Soares M, Chuang L, Worthy G, Bland M, Iglesias C, Cullum N, Torgerson D, Nelson E. VenUS III: a randomised controlled trial of therapeutic ultrasound in the management of venous leg ulcers. Health Technol Assess 2011, 15:1-176.
3. Walker A, Nixon J. Improving the quality of reporting in randomised controlled trials. J Wound Care 2004, 13:103-106.
4. Werdin F, Tennenhaus M, Schaller H, Rennekampff H. Evidence-based management strategies for treatment of chronic wounds. Eplasty 2009, 9:e19. 2691645, 19578487.
5. Gottrup F, Apelqvist J, Price P. Outcomes in controlled and comparative studies on non-healing wounds: recommendations to improve the quality of evidence in wound management. J Wound Care 2010, 19:237-268.
6. Kjaergard L, Villumsen J, Gluud C. Reported methodological quality and discrepancies between large and small randomized trials in meta-analyses. Ann Intern Med 2001, 135:982-989. 10.7326/0003-4819-135-11-200112040-00010, 11730399.
7. Jüni P, Altman D, Egger M. Systematic reviews in health care: assessing the quality of controlled clinical trials. BMJ 2001, 323:42-46. 10.1136/bmj.323.7303.42, 1120670, 11440947.
8. Egger M, Juni P, Bartlett C, Holenstein F, Sterne J. How important are comprehensive literature searches and the assessment of trial quality in systematic reviews: empirical study. Health Technol Assess 2003, 7:1.
9. Woods L, Egger M, Gluud L, Schulz K, Jüni P, Altman D, Gluud C, Martin R, Wood A, Sterne J. Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study. BMJ 2008, 336:601-605. 10.1136/bmj.39465.451748.AD, 2267990, 18316340.
10. Nüesch E, Reichenbach S, Trelle S, Rutjes S, Liewald K, Sterchi R, Altman D, Jüni P. The importance of allocation concealment and patient blinding in osteoarthritis trials: a meta-epidemiologic study. Arthritis Rheumatism 2009, 61:1633-1641. 10.1002/art.24894, 19950329.
11. Hróbjartsson A, Thomsen A, Emanuelsson F, Tendal B, Hilden J, Boutron I, Ravaud P, Brorson S. Observer bias in randomised clinical trials with binary outcomes: systematic review of trials with both blinded and non-blinded outcome assessors. BMJ 2012, 344:e1119. 10.1136/bmj.e1119, 22371859.
12. Savovic' J, Jones H, Altman D, Harris RJ, Jüni P, Pildal J, Als-Nielsen B, Balk E, Gluud C, Gluud L, Ioannidis J, Schulz K, Beynon R, Welton N, Wood L, Moher D, Deeks J, Sterne J. Influence of reported study design characteristics on intervention effect estimates from randomized controlled trials. Ann Intern Med 2012, 157:429-438. 10.7326/0003-4819-157-6-201209180-00537, 22945832.
13. Kirkham J, Dwan K, Altman D, Gamble C, Dodd S, Smyth R, Williamson P. The impact of outcome reporting bias in randomised controlled trials on a cohort of systematic reviews. BMJ 2010, 340:c365. 10.1136/bmj.c365, 20156912.
14. Singh J, Murphy S, Bhandari M. Trial sample size, but not trial quality, is associated with positive study outcome. J Clin Epidemiol 2010, 63:154-162. 10.1016/j.jclinepi.2009.05.007, 2818000, 19716266.
15. Chan A, Altman D. Epidemiology and reporting of randomised trials published in PubMed journals. Lancet 2005, 365:1159-1162. 10.1016/S0140-6736(05)71879-1, 15794971.
16. Hopewell S, Dutton S, Yu L, Chan A, Altman D. The quality of reports of randomised trials in 2000 and 2006: comparative study of articles indexed in PubMed. BMJ 2010, 340:c723. 10.1136/bmj.c723, 2844941, 20332510.
17. Hui D, Arthur J, Dalal S, Bruera E. Quality of the supportive and palliative oncology literature: a focused analysis on randomized controlled trials. Support Care Cancer 2012, 20:1779-1785. 10.1007/s00520-011-1275-9, 21935717.
18. Shuai P, Zhou X, Lao L, Li X. Issues of design and statistical analysis in controlled clinical acupuncture trials: an analysis of English-language reports from Western journals. Stat Med 2010, 31:606-618.
19. Strippoli G, Craig J, Schena F. The number, quality and coverage of randomized controlled trials in nephrology. J Am Soc Nephrol 2004, 15:411-419. 10.1097/01.ASN.0000100125.21491.46, 14747388.
20. Danilla S, Wasiak J, Searle S, Arrigada C, Pedreros C, Cleland H, Spinks A. Methodological quality of randomised controlled trials in burns care. A Syst Rev Burns 2009, 35:956-961.
21. Yaphe J, Edman R, Knishkowy B, Herman J. The association between funding by commercial interests and study outcome in randomized controlled drug trials. Fam Pract 2001, 18:565-568. 10.1093/fampra/18.6.565, 11739337.
22. Lexchin J, Bero L, Djulbegovic B, Clark O. Pharmaceutical industry sponsorship and research outcome and quality: systematic review. BMJ 2003, 326:1167-1170. 10.1136/bmj.326.7400.1167, 156458, 12775614.
23. Perlis R, Perlis C, Wu Y, Hwang C, Joseph M, Nierenberg A. Industry sponsorship and financial conflict of interest in the reporting of clinical trials in psychiatry. Am J Psychiatry 2005, 162:1957-1960. 10.1176/appi.ajp.162.10.1957, 16199844.
24. Lundh A, Sismondo S, Lexchin J, Busuioc O, Bero L. Industry sponsorship and research outcome. Cochrane Database of Syst Rev 2012, doi:10.1002/14651858.MR000033.pub2.
25. Ioannidis J. Effect of the statistical significance of results on the time to completion and publication of randomized efficacy trials. JAMA 1998, 279:281-286. 10.1001/jama.279.4.281, 9450711.
26. Mandelkern M. Manufacturer support and outcome. J Clin Psychiatry 1999, 60:122-123.
27. Djulbegovic B, Lacevic M, Cantor A, Fields K, Bennett C, Adams J, Kuderer N, Lyman G. The uncertainty principle and industry-sponsored research. Lancet 2000, 356:635-638. 10.1016/S0140-6736(00)02605-2, 10968436.
28. Cho M, Bero L. The quality of drug studies published in symposium proceedings. Ann Intern Med 1996, 124:485-489. 10.7326/0003-4819-124-5-199603010-00004, 8602706.
29. Kjaergard L, Nikolova D, Gluud C. Randomized clinical trials in Hepatology: predictors of quality. Hepatology 1999, 30:1134-1138. 10.1002/hep.510300510, 10534332.
30. Jones R, Younie S, Macallister A, Thornton J. A comparison of the scientific quality of publicly and privately funded randomized controlled drug trials. J Eval Clin Pract 2010, 16:1322-1325. 10.1111/j.1365-2753.2009.01335.x, 20738476.
31. Higgins J, Altman D, Gotzsche P, Juni P, Moher D, Oxman A, Savovic J, Schulz K, Weeks L, Sterne J. Cochrane Bias Methods Group The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ 2011, 343:d5928. 10.1136/bmj.d5928, 3196245, 22008217, Cochrane Bias Methods Group.
32. Higgins J, Green S. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0. [http://www.cochrane-handbook.org].
33. Iglesias C, Nelson E, Cullum N, Torgerson D. on behalf of the VenUS Team VenUS I: a randomised controlled trial of two types of bandage for treating venous leg ulcers. Health Technol Assess 2004, 8:1e120. on behalf of the VenUS Team.
34. Halpern S, Karlawish J, Berlin J. The continuing unethical conduct of underpowered clinical trials. JAMA 2002, 288:358-362. 10.1001/jama.288.3.358, 12117401.
35. Bacchetti P. Current sample size conventions: flaws, harms, and alternatives. BMC Med 2010, 8:17. 10.1186/1741-7015-8-17, 2856520, 20307281.
36. Norman G, Monteiro S, Salama S. Sample size calculations: should the emperor's clothes be off the peg or made to measure?. BMJ 2012, 345:e5278. 10.1136/bmj.e5278, 22918496.
37. Lockyer S. An investigation into the reporting and interpretation of randomised controlled trials in wound care where the primary outcomes are statistically non-significant or unclear 2012, MSc. thesis: University of York, Department of Health Sciences.
38. Cardinal M, Eisenbud D, Phillips T, Harding K. Early healing rates and wound area measurements are reliable predictors of later complete wound closure. Wound Repair Regen 2008, 16:19-22. 10.1111/j.1524-475X.2007.00328.x, 18211575.
39. Edsberg L, Wyffels J, Daniel H. Longitudinal Study of Stage III and Stage IV Pressure Ulcer Area and Perimeter as Healing Parameters to Predict Wound Closure. Ostomy Wound Manag 2011, 57:50-62.
40. O'Meara S, Bland M, Dumville J, Cullum N. A systematic review of the performance of instruments designed to measure the dimensions of pressure ulcers. Wound Repair Regen 2012, 20:263-276. 10.1111/j.1524-475X.2012.00783.x, 22564222.
41. Gelfand J, Hoffstad O, Margolis D. Surrogate endpoints for the treatment of venous leg ulcers. J Investig Dermatol 2002, 119:1420-1425. 10.1046/j.1523-1747.2002.19629.x, 12485449.
42. Berger V. Does the Prentice criteria validate surrogate endpoints?. Stat Med 2004, 23:1571-1578. 10.1002/sim.1780, 15122737.
43. Devereaux P, Choi P, El-Dika S, Bhandari M, Montori V, Schunemann H, Garg A, Busse J, Heels-Ansdell D, Ghali W, Manns B, Guyatt G. An observational study found that authors of randomized controlled trials frequently use concealment of randomization and blinding, despite the failure to report these methods. J Clin Epidemiol 2004, 57:1232-1236. 10.1016/j.jclinepi.2004.03.017, 15617948.
44. Soares H, Daniels S, Kumar A, Clarke M, Scott C, Swann S, Djulbegovic B. Radiation Therapy Oncology Group Bad reporting does not mean bad methods for randomised trials: observational study of randomised controlled trials performed by the Radiation Therapy Oncology Group. BMJ 2004, 328:22-24. 10.1136/bmj.328.7430.22, 313900, 14703540, Radiation Therapy Oncology Group.
45. Egger M, Zellweger-Zahner T, Schneider M, Junker C, Lengeler C, Antes G. Language bias in randomised controlled trials published in English and German. Lancet 1997, 350:326e9.
46. Moher D, Fortin P, Jadad A, Juni P, Klassen T, Le Lorier J, Liberati A, Linde K, Penna A. Completeness of reporting of trials published in languages other than English: implications for conduct and reporting of systematic reviews. Lancet 1996, 347:363e6.
47. Juni P, Holenstein F, Sterne J, Bartlett C, Egger M. Direction and impact of language bias in meta-analyses of controlled trials: empirical study. Int J Epidemiol 2002, 31:115e23.
48. Shiwa S, Moseley A, Maher C, Pena Costa L. Language of publication has a small influence on the quality of reports of controlled trials of physiotherapy interventions. J Clin Epidemiol 2013, 66:78-84. 10.1016/j.jclinepi.2012.08.004, 23177897.
49. Eskes AM, Brölmann FE, Sumpio BE, Mayer D, Moore Z, Agren MS, Hermans M, Cutting K, Legemate DA, Ubbink DT, Vermeulen H. Fundamentals of randomized clinical trials in wound care: design and conduct. Wound Repair Regen 2012, 20:449-455.
50. Hollisaz M, Khedmat H, Yari F. A randomized clinical trial comparing hydrocolloid, phenytoin and simple dressings for the treatment of pressure ulcers. BMC Dermatol 2004, 4:18. 10.1186/1471-5945-4-18, 545970, 15601464.
51. Dumville J, Worthy G, Soares M, Bland M, Cullum N, Dowson C, Iglesias C, McCaughan D, Mitchell JL, Nelson EA, Torgerson DJ. VenUS II team VenUS II: a randomised controlled trial of larval therapy in the management of leg ulcers. Health Technol Assess 2009, 13:1-182. VenUS II team.
52. Sonnad S, Goldsack J, Mohr P, Whicher D. Methodological Recommendations for Comparative Effectiveness Research on the Treatment of Chronic Wounds. [http://www.cmtpnet.org/wp-content/uploads/downloads/2012/10/Wound-Care-2012.pdf].